Search Results for “” – Page 9 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Economics

181 Publications found

Cost-effectiveness of health technologies in adults with type 1 diabetes: a systematic review and narrative synthesis.

b

Systematic reviews

August 3, 2020

p Diabetes

c Change patient management Economics Meta-analysis
Estimating the Cost of Point-of-Care Early Infant Diagnosis in a Program Setting: A Case Study Using Abbott m-PIMA and Cepheid GeneXpert IV in Zimbabwe.

b

Journal of acquired immune deficiency syndromes (1999)

July 1, 2020

p HIV POCT

c Economics Observational
The cost-effectiveness of conducting three versus two reverse transcription-polymerase chain reaction tests for diagnosing and discharging people with COVID-19: evidence from the epidemic in Wuhan, China.

b

BMJ global health

July 1, 2020

p COVID-19

c Economics Model
Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis.

b

Journal of acquired immune deficiency syndromes (1999)

July 1, 2020

p HIV POCT

c Economics Model
Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States.

b

JAMA network open

July 1, 2020

p COVID-19

c Economics Model
A model-based economic evaluation of four newborn screening strategies for cystic fibrosis in Flanders, Belgium.

b

Acta clinica Belgica

June 1, 2020

p Newborn Screening

c Economics Model
Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial.

b

Gut

April 1, 2020

p Inflammatory Bowel Disease

c Clinical outcomes Economics Model
Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases.

b

Genetics in medicine : official journal of the American College of Medical Genetics

March 1, 2020

p Pharmacogenetic and Pharmacogenomics

c Economics Review
Clinical value and cost saving of therapeutic drug monitoring of infliximab in adult patients with inflammatory bowel disease.

b

Clinical medicine (London, England)

March 1, 2020

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Economics Observational
The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial.

b

BMC infectious diseases

January 17, 2020

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Economics Trial protocol